Login to Your Account

Pharma: Clinic Roundup

Tuesday, July 2, 2013
• Bristol-Myers Squibb Co., of Princeton, N.J., and Pfizer Inc., of New York, reported results of the six-month Phase III AMPLIFY trial of 5,395 patients with acute venous thromboembolism (VTE), which includes symptomatic deep vein thrombosis (DVT) and/or pulmonary embolism (PE).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription